ERBB2 and metastatic neoplasm: There were no differences in treatment patterns according to ER status of metastatic disease (Pearson’s chi-square p = 0.307), HER2 expression at metastatic disease (Pearson’s chi-square p = 0.077), or DRFI (Pearson’s chi-square p = 0.658).